XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2023
Stock-Based Compensation Expense by Award Type

The Company’s stock-based compensation expense by award type was as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Stock options

 

$

7,416

 

 

$

8,825

 

 

$

15,594

 

 

$

18,092

 

Restricted stock units

 

 

2,852

 

 

 

1,258

 

 

 

5,632

 

 

 

2,511

 

Employee stock purchase plan

 

 

236

 

 

 

252

 

 

 

484

 

 

 

532

 

 

 

$

10,504

 

 

$

10,335

 

 

$

21,710

 

 

$

21,135

 

Stock-Based Compensation Expense

The Company recorded aggregate stock-based compensation expense in the consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Research and development

 

$

5,470

 

 

$

5,405

 

 

$

11,540

 

 

$

11,075

 

General and administrative

 

 

5,034

 

 

 

4,930

 

 

 

10,170

 

 

 

10,060

 

 

 

$

10,504

 

 

$

10,335

 

 

$

21,710

 

 

$

21,135

 

Summary of Unvested RSUs Activity Under 2015 Plan

The following table summarizes restricted stock unit activity under the 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

Weighted-average

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested balance at December 31, 2022

 

 

613

 

 

$

35.41

 

Granted

 

 

1,005

 

 

$

22.14

 

Vested

 

 

(146

)

 

$

36.31

 

Forfeited

 

 

(48

)

 

$

27.37

 

Unvested balance at June 30, 2023

 

 

1,424

 

 

$

26.22

 

 

2014 and 2015 Equity Incentive Plan [Member]  
Summary of Stock Option Activity

The following table summarizes stock option activity under the 2014 Plan and 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

average

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

Exercise

 

 

Life

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

(Years)

 

 

Value (a)

 

Outstanding at December 31, 2022

 

 

7,668

 

 

$

34.43

 

 

 

6.5

 

 

$

15,783

 

Granted

 

 

1,661

 

 

$

21.99

 

 

 

 

 

 

 

Exercised

 

 

(165

)

 

$

7.40

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(259

)

 

$

36.73

 

 

 

 

 

 

 

Outstanding at June 30, 2023

 

 

8,905

 

 

$

32.54

 

 

 

6.7

 

 

$

9,867

 

Exercisable at June 30, 2023

 

 

5,781

 

 

$

34.41

 

 

 

5.5

 

 

$

9,798

 

Vested and expected to vest at June 30, 2023

 

 

8,905

 

 

$

32.54

 

 

 

6.7

 

 

$

9,867

 

 

(a) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that were in the money at the dates reported.